• Cytokinetics EVP, Research & Development Malik Fady Ibraham exercised 3,500 shares of common stock options at USD 7.8 on July 21, 2026.
• He sold 3,500 common shares the same day at USD 80.59.
• He reported 153,902 common shares owned following the transactions.
• He reported 33,886 non-qualified stock options remaining after the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000084), on July 23, 2026, and is solely responsible for the information contained therein.